Evonik Operations Gmbh

Evonik Roehm Gmbh

Anne Benedikt

Norbert Windhab

Andrea Engel

Christian Kessler

Martin Schilling

Matthias Germer

Melanie Liefke

Silko Grimm

Bodo Speckmann

Mario Gomez

Ines Ochrombel

Jens Daufenbach

Jessica Müller-Albers

Tom Tice

Maria Steinke

Jean-Luc Herbeaux

Jochen Bodem

Rike Nabbefeld

Steffen Kistner

Susanne Ullrich

Juan Tome-Alcalde

Jürgen Dieker

Alexander Henrik Baron Van Asbeck

Roland Brock

A preparation containing a mixture of at least one phospholipid, and at least one fatty acid salt of a cation with an anion derived from a fatty acid. A method for preparing such preparation and the use of such preparation to provide polyunsaturated fatty acids to cells, tissues, organs or organisms, for example in the field of cell and tissue culture, organ preservation, human or animal nutrition, or cosmetics.

Preparation comprising a dispersion of phospholipids and fatty acid salts

A composition may be used in treating or preventing a virus infection in a subject, wherein the virus is from the Paramyxoviridae family and wherein the composition includes an extract of black currants and bilberries. The composition may contain an extract from black currants and bilberries in a weight ratio in a range of from 0.5:1 to 1:0.5. The extract may be an alcoholic extract, such as a methanol extract. The composition may be administered to the subject 1 to 10 oral dosages of at least 80 mg anthocyanins each per day, preferably 3 to 6 oral dosages of at least 80 mg anthocyanins each per day. The subject may not have received a measles vaccination or have previously been exposed to the measles virus.

Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by Paramyxoviridae

A nanoparticle includes a core. The core includes a bio-resorbable polyester and a hydrophilic polymer. The hydrophilic polymer is a portion of the bio-resorbable polyester or a separate polymer. An acylated human lactoferrin-derived peptide is coated onto the core. The acylated human lactoferrin-derived peptide is a peptide with the amino acid sequence SEQ ID NO. 1: KCFQWQRNMRKVRGPPVSCIKR or an amino acid sequence, which does not differ by more than 8 amino acid positions from the sequence SEQ ID NO: 1. The N-terminus of the human lactoferrin-derived peptide is acylated with a C-monoacyl group.

Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide

A process for preparing a powder, which includes one or more human coagulation factor proteins and a lactic acid polymer, involves mixing and dispersing a lactic acid polymer with a particle size din the range 0.1-2 &#x3bc;m and the one or more human coagulation factor proteins in water. The dispersion is dried, and the resulting dried mass is compressed. The resulting compressed dried mass is comminuted to a powder with a particle size din the range of more than 0.5 and up to 5 &#x3bc;m.

Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymer

Growing community of inventors

Frankfurt-am-Main, Germany

Anne Benedikt